Physiology of the lung in idiopathic pulmonary fibrosis

The clinical expression of idiopathic pulmonary fibrosis (IPF) is directly related to multiple alterations in lung function. These alterations derive from a complex disease process affecting all compartments of the lower respiratory system, from the conducting airways to the lung vasculature. In this article we review the profound alterations in lung mechanics (reduced lung compliance and lung volumes), pulmonary gas exchange (reduced diffusing capacity, increased dead space ventilation, chronic arterial hypoxaemia) and airway physiology (increased cough reflex and increased airway volume), as well as pulmonary haemodynamics related to IPF. The relative contribution of these alterations to exertional limitation and dyspnoea in IPF is discussed. Physiological impairment in IPF is complex and involves all compartments of the respiratory system http://ow.ly/gyao30hdHUb

[1]  S. Rosselot Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[3]  D. Johnson,et al.  Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. , 2000, Respiratory medicine.

[4]  J. Milic-Emili,et al.  The pattern of breathing in diffuse lung fibrosis. , 1982, Bulletin europeen de physiopathologie respiratoire.

[5]  L. Plantier,et al.  Cross-Sectional Assessment of the Relationships between Dyspnea Domains and Lung Function in Diffuse Parenchymal Lung Disease , 2013, Respiration.

[6]  V. Melenovský,et al.  Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications , 2015, European journal of heart failure.

[7]  R. D. du Bois,et al.  Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis , 2016, Thorax.

[8]  A. Alavi,et al.  Scintigraphic diagnosis of a right to left shunt in end-stage lung disease. , 2003, Respiratory medicine.

[9]  V. Brusasco,et al.  Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias , 2016 .

[10]  P. Calverley,et al.  Cryptogenic fibrosing alveolitis with preserved lung volumes. , 1997, Thorax.

[11]  P. Spagnolo,et al.  Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine , 2016, Journal of Medical Genetics.

[12]  J. Neder,et al.  Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders. , 2016, American journal of respiratory and critical care medicine.

[13]  H. Collard,et al.  A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.

[14]  K. McCarthy,et al.  Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis. , 2012, Respiratory Medicine.

[15]  V. Poletti,et al.  Abnormal Re-epithelialization and Lung Remodeling in Idiopathic Pulmonary Fibrosis: The Role of ΔN-p63 , 2002, Laboratory Investigation.

[16]  C. Carvalho,et al.  Effects of proportional assisted ventilation on exercise performance in idiopathic pulmonary fibrosis patients. , 2010, Respiratory medicine.

[17]  Bruce D. Johnson,et al.  Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction. , 2016, JACC. Heart failure.

[18]  J. Holmes,et al.  Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis. , 2013, Chest.

[19]  T. Honda,et al.  Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction , 2014, International journal of chronic obstructive pulmonary disease.

[20]  O. Nishiyama,et al.  Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. , 2013, Respiratory medicine.

[21]  W. Seeger,et al.  Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[22]  W. C. Miller,et al.  Anatomical lung shunting in pulmonary fibrosis. , 1986, Thorax.

[23]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[24]  S. Miriuka,et al.  Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature. , 2010, American Heart Journal.

[25]  D. Lockwood,et al.  DLCO/Q and diffusion limitation at rest and on exercise in patients with interstitial fibrosis. , 1991, Respiration physiology.

[26]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[27]  P. Filardi,et al.  Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension , 2012, European journal of preventive cardiology.

[28]  Kevin Flaherty,et al.  Pulmonary function testing in idiopathic interstitial pneumonias. , 2006, Proceedings of the American Thoracic Society.

[29]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[30]  C. Roussos,et al.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study , 2010, BMC pulmonary medicine.

[31]  L. Forkert,et al.  Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis. , 2014, Canadian respiratory journal.

[32]  P. Vaida,et al.  Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. , 1987, Respiration physiology.

[33]  P. O'Byrne,et al.  Is nedocromil sodium effective treatment for asthma? , 1993, The European respiratory journal.

[34]  S. Nathan,et al.  Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis. , 2017, Journal of managed care & specialty pharmacy.

[35]  A. Nicholson,et al.  Interstitial vascularity in fibrosing alveolitis. , 2003, American journal of respiratory and critical care medicine.

[36]  J. Jamart,et al.  Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis. , 2013, Respiratory medicine.

[37]  D. Hansell,et al.  Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. , 1997, American journal of respiratory and critical care medicine.

[38]  S. Ohlmeier,et al.  Peroxiredoxin II Expression and Its Association With Oxidative Stress and Cell Proliferation in Human Idiopathic Pulmonary Fibrosis , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  S. Nathan,et al.  Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant , 2007, European Respiratory Journal.

[40]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[41]  A. Azuma,et al.  A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .

[42]  K. P. Van de Woestijne,et al.  Total respiratory resistance and reactance in patients with diffuse interstitial lung disease. , 1989, The European respiratory journal.

[43]  Yoshitaka Tateishi,et al.  Acidosis and raised norepinephrine levels are associated with exercise dyspnoea in idiopathic pulmonary fibrosis , 2009, Respirology.

[44]  L. Fasano,et al.  The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. , 2006, Respiratory care.

[45]  J. Hughes,et al.  Estimating exercise DLO2 and diffusion limitation in patients with interstitial fibrosis. , 1991, Respiration physiology.

[46]  D. Hansell,et al.  Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis , 2017, European Respiratory Journal.

[47]  M. Terzano,et al.  Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis. , 2016, Sleep medicine reviews.

[48]  M. Sears Predicting asthma outcomes. , 2015, The Journal of allergy and clinical immunology.

[49]  Pedro Lopes de Melo,et al.  Correlação dos achados tomográficos com parâmetros de função pulmonar na fibrose pulmonar idiopática em não fumantes* Correlation of tomographic findings with pulmonary function parameters in nonsmoking patients with idiopathic pulmonary fibrosis , 2007 .

[50]  N. Isern,et al.  Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. , 2012, American journal of respiratory and critical care medicine.

[51]  A. Montgomery,et al.  Ambulatory oxygen in interstitial lung disease , 2011, European Respiratory Journal.

[52]  F. Martinez,et al.  Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification , 2005, Thorax.

[53]  I. Tillie‐Leblond,et al.  Do We Need Exercise Tests to Detect Gas Exchange Impairment in Fibrotic Idiopathic Interstitial Pneumonias? , 2012, Pulmonary medicine.

[54]  R. D. du Bois,et al.  Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials. , 2016, Respiratory medicine.

[55]  A. Holland,et al.  Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia , 2017, Respirology.

[56]  A. Kotanidou,et al.  The Role of Cardiopulmonary Exercise Test in IPF Prognosis , 2013, Pulmonary medicine.

[57]  G. Oster,et al.  Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.

[58]  D. Streiner,et al.  Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. , 2014, Respiratory medicine.

[59]  T. Perez,et al.  Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. , 2012, Respiratory medicine.

[60]  W. Thurlbeck,et al.  Correlation of structure and function in idiopathic pulmonary fibrosis. , 1995, American journal of respiratory and critical care medicine.

[61]  L. Spencer,et al.  Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? , 2012, European Respiratory Journal.

[62]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[63]  S. Hashimoto,et al.  [Assessment of pulmonary aerosol deposition and epithelial permeability in 99mTc-DTPA inhalation scintigram]. , 1993, Nihon Kyobu Shikkan Gakkai zasshi.

[64]  M. Zorzetto,et al.  A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant , 2014, Respiratory Research.

[65]  H. Collard,et al.  The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. , 2015, Respiratory medicine.

[66]  S. Harari,et al.  Cellular interactions in the pathogenesis of interstitial lung diseases , 2015, European Respiratory Review.

[67]  J. Barberà,et al.  Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis. , 2011, Journal of applied physiology.

[68]  M. Cazzola,et al.  Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. , 2016, Pulmonary pharmacology & therapeutics.

[69]  K. Flaherty,et al.  A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis , 2018, American journal of respiratory and critical care medicine.

[70]  L. Voltolini,et al.  Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience , 2015, Lung.

[71]  G. Raghu,et al.  Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review , 2015, European Respiratory Journal.

[72]  P. Revy,et al.  Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis , 2016, European Respiratory Journal.

[73]  N. Cherniack,et al.  Occlusion pressure and breathing pattern in patients with interstitial lung disease. , 2015, The American review of respiratory disease.

[74]  Hui Liu,et al.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. , 2013, The Journal of clinical investigation.

[75]  E. Rosenberg The 1995 update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor) , 1996, American journal of respiratory and critical care medicine.

[76]  B. Nemery,et al.  Effect of alveolar volume on the interpretation of single breath DLCO. , 1997, Respiratory medicine.

[77]  D. Schwartz,et al.  The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium , 2013, PloS one.

[78]  Joyce S Lee,et al.  A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.

[79]  R. Wells,et al.  Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute. , 2014, The American journal of pathology.

[80]  J D Fulmer,et al.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. , 1979, The Journal of clinical investigation.

[81]  B. Porse,et al.  Open Access Research , 2022 .

[82]  A. Wanner,et al.  Influence of lung inflation on the cross-sectional area of central airways in normals and in patients with lung disease. , 1981, Respiration; international review of thoracic diseases.

[83]  R. Borie,et al.  Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background , 2012, Current opinion in pulmonary medicine.

[84]  R. Eccles,et al.  Mechanical induction of cough in Idiopathic Pulmonary Fibrosis , 2010, Cough.

[85]  U. Demkow,et al.  Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function , 2010, European journal of medical research.

[86]  H. Gin,et al.  Nitrogen monoxide and carbon monoxide transfer interpretation: state of the art , 2017, Clinical physiology and functional imaging.

[87]  Stefano Nava,et al.  Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis , 1999, Thorax.

[88]  S. Leroy,et al.  Fibrose pulmonaire idiopathique et shunt droit-gauche par foramen ovale perméable : amélioration clinique et gazométrique après fermeture percutanée , 2007 .

[89]  Ivana V. Yang,et al.  A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.

[90]  J. Roca,et al.  Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis. , 1988, The European respiratory journal.

[91]  H. Collard,et al.  Pirfenidone Reduces Respiratory‐related Hospitalizations in Idiopathic Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.

[92]  K. Snibson,et al.  Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis , 2015, BMC Pulmonary Medicine.

[93]  K. Anstrom,et al.  The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. , 2012, Respiratory medicine.

[94]  F. Martinez,et al.  CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab , 2015, European Respiratory Journal.

[95]  J. Whitsett,et al.  Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis , 2011, Thorax.

[96]  F. Martinez,et al.  Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction , 2015, European Respiratory Journal.

[97]  F. Gigliotti,et al.  Neural respiratory drive and neuromuscular coupling during CO2 rebreathing in patients with chronic interstitial lung disease. , 1989, Chest.

[98]  L. Plantier,et al.  Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases , 2015, BMC Pulmonary Medicine.

[99]  H. Collard,et al.  Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management , 2017, Front. Med..

[100]  J. E. Hansen,et al.  Cardiac output estimated noninvasively from oxygen uptake during exercise. , 1997, Journal of applied physiology.

[101]  N. Strickland,et al.  Cause of regional ventilation-perfusion mismatching in patients with idiopathic pulmonary fibrosis: a combined CT and scintigraphic study. , 1993, AJR. American journal of roentgenology.

[102]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[103]  R. D. du Bois,et al.  Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. , 2011, Chest.

[104]  R. Newton,et al.  A study of the cough reflex in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[105]  Y. Kondoh,et al.  Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD. , 2007, Respiratory medicine.

[106]  J. Roca,et al.  Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. , 1994, The European respiratory journal.

[107]  S. Harari,et al.  Pulmonary hypertension in chronic interstitial lung diseases , 2013, European Respiratory Review.

[108]  A. Nicholson,et al.  Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.

[109]  G. Ferretti,et al.  Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines , 2014, European Respiratory Review.

[110]  F. Martinez,et al.  Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema , 2010, European Respiratory Journal.

[111]  L. Farkas,et al.  Angiogenesis in pulmonary fibrosis: too much or not enough? , 2012, Chest.

[112]  J. Roca,et al.  Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. , 1991, The American review of respiratory disease.

[113]  H. Collard,et al.  Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. , 2017, The Lancet. Respiratory medicine.

[114]  G. Raghu,et al.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[115]  S. Nathan,et al.  Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. , 2007, American journal of respiratory and critical care medicine.

[116]  R. Hubbard,et al.  The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. , 2008, American journal of respiratory and critical care medicine.

[117]  W. Seeger,et al.  Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. , 1999, The European respiratory journal.

[118]  M. Mishima,et al.  Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. , 2007, Chest.

[119]  Manuela Muratori,et al.  Gas diffusion and alveolar-capillary unit in chronic heart failure. , 2006, European heart journal.

[120]  M. Bran,et al.  Respiratory drive and ventilatory pattern during exercise in interstitial lung disease. , 1981, Bulletin europeen de physiopathologie respiratoire.

[121]  Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.

[122]  S. Nathan,et al.  Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. , 2007, Chest.

[123]  J. Curtis,et al.  The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. , 1995, Chest.

[124]  長尾 光修 The Lung: Scientific Foundations , 1997 .

[125]  A. Wells,et al.  Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis , 2014, Respirology.

[126]  K. Wasserman,et al.  Exercise capacity in idiopathic pulmonary fibrosis: The effect of pulmonary hypertension , 2011, Respirology.

[127]  D. Schwartz,et al.  The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population , 2013, PloS one.

[128]  J. Heyder,et al.  Aerosol-derived airway morphometry and aerosol bolus dispersion in patients with lung fibrosis and lung emphysema. , 1999, Chest.

[129]  Y. Castier,et al.  Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. , 2007, Human pathology.

[130]  D. Jastrzębski,et al.  [Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis with inspiratory muscle training]. , 2008, Pneumonologia i alergologia polska.

[131]  L. Plantier,et al.  Increased volume of conducting airways in idiopathic pulmonary fibrosis is independent of disease severity: a volumetric capnography study , 2016, Journal of breath research.

[132]  Takashi Suzuki,et al.  Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. , 2004, American journal of respiratory and critical care medicine.

[133]  J. Jeudy,et al.  Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[134]  Rohan S. Virgincar,et al.  Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis , 2017, Thorax.

[135]  W. Galetke,et al.  Reference values for dynamic and static pulmonary compliance in men. , 2007, Respiratory medicine.

[136]  Meilan K. Han,et al.  Predicting pulmonary fibrosis disease course from past trends in pulmonary function. , 2014, Chest.

[137]  S. Sahn,et al.  Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.

[138]  P. Paré,et al.  Correlation between pulmonary fibrosis and the lung pressure-volume curve , 2004, Lung.